--- title: "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin" ocid: "ocds-h6vhtk-048730" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-048730" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-048730.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-048730.json" source: "Find A Tender Service" current_stage: "Award" buyer: "NHS ENGLAND" published: "2025-01-20" --- # NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin Buyer: NHS ENGLAND Current stage: Award OCID: ocds-h6vhtk-048730 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-048730) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-048730.json) ## Summary NHS England has initiated an open procurement process under the NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin, covering the period from 1 April 2025 to 31 December 2027. The procurement falls under the industry category of immunoglobulins, with the primary procurement category being goods. The agreement includes options for extensions up to 15 months, making the total potential duration of the framework up to 48 months. The procurement stage is currently in the award phase, with contracts awarded as of December 2024. The total estimated value of the framework is GBP 1.7 billion, encompassing six lots covering various immunoglobulin products, with key suppliers such as CSL Behring UK Limited, Grifols UK (Diagnostics), Octapharma Limited, Takeda UK Limited, BIO PRODUCTS LABORATORY LIMITED, and LFB BIOMEDICAMENTS participating. This tender presents substantial opportunities for businesses specializing in the production and supply of immunoglobulins. Large-scale suppliers with robust supply chains and the capability to meet NHS standards and requirements are particularly well-suited to compete in this framework. Participation in this tender allows companies to secure significant market share and establish long-term relationships with NHS bodies, thereby driving growth and expanding market presence in the UK healthcare sector. Interested suppliers should ensure they meet all procurement criteria and deadlines to leverage this notable business opportunity. ## Notice NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin Offer reference number: CM/PHS/23/5703 The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. ### Lot Information Lot 1 - Low and High Strength Albumin NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin Offer reference number: CM/PHS/23/5703 Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents. Lot 2 - 5% Intravenous Immunoglobulin NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin Offer reference number: CM/PHS/23/5703 Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents. Lot 3 - 10% Intravenous Immunoglobulin NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin Offer reference number: CM/PHS/23/5703 Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents. Lot 4 - Subcutaneous Immunoglobulin NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin Offer reference number: CM/PHS/23/5703 Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents. Lot 5 - Facilitated Subcutaneous Immunoglobulin NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin Offer reference number: CM/PHS/23/5703 Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents. Lot 6 - Anti-D Immunoglobulin NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin Offer reference number: CM/PHS/23/5703 Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/001899-2025 | | Notice type | Tender Notice | | Procurement type | Framework | | Procurement category | Goods | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Large, SME | | All stages | Tender, Award | ## Dates | Field | Value | | --- | --- | | Publication date | 20 Jan 2025 | | Submission deadline | 13 Sep 2024 | | Future notice date | Not specified | | Award date | 19 Dec 2024 | | Contract period | 31 Mar 2025 - 31 Dec 2027 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £1,700,000,000 | | Lots value | £5 | | Awards value | Not specified | | Contracts value | £1 | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Cancelled | | Awards status | Active | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | NHS ENGLAND | | Locality | LEEDS | | Post town | Leeds | | Postcode | LS1 4AP | | Country | England | | ITL 1 | TLE Yorkshire and The Humber | | ITL 2 | TLE4 West Yorkshire | | ITL 3 | TLE42 Leeds | | Local authority | Leeds | | Electoral ward | Hunslet & Riverside | | Westminster constituency | Leeds South | | Delivery location | Not specified | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 6 | | Supplier names | BIO PRODUCTS LABORATORY; CSL BEHRING; GRIFOLS UK (DIAGNOSTICS; LFB BIOMEDICAMENTS; OCTAPHARMA; TAKEDA | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33651520 - Immunoglobulins ## Release History - 20 Jan 2025 at 15:25 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/001899-2025 - 2 Aug 2024 at 12:44 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/024312-2024 ## Notice URLs - http://www.bpl.co.uk - http://www.cslbehring.co.uk - http://www.octapharma.co.uk - http://www.takeda.co.uk - https://health-family.force.com/s/Welcome - https://www.england.nhs.uk/ - https://www.england.nhs.uk// - https://www.groupe-lfb.com/ - https://www.judiciary.uk/courts-and-tribunals/high-court/ ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-048730. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-048730.json.